The EyeOP1 is a new medical device developed by EyeTechCare that uses therapeutic ultrasound to enable non-invasive treatment of refractory glaucoma.  The treatment can be administered on an outpatient basis and is performed under local anaesthaesia.  The patient simply lies down close to the command module and a disposable therapy device is placed on the globe of the eyeball.

An initial pilot study of the device demonstrated efficacy with results presented at ARVO in May 2011 (view detailed results here ^[1]).

Presently, plans are underway for expanded studies at 20 medical centers around the world to further evaluate the effectiveness and the safety of the EYEOP1 device to treat glaucoma. One recently announced such study will be conducted at the Sam Rothberg Glaucoma Center of the Goldschleger Eye Institute at Sheba Medical Center in Israel (click here ^[2] to learn more about the study at this location).

The primary objective of these studies is to demonstrate reduction of baseline IOP by more than 20% in participating patients after 12 months.